N/A
Completed N=339
ACHIEVE Hearing Intervention Follow-Up Study
Source: ClinicalTrials.gov NCT05070429 ↗Enrolled (actual)
339
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Average Daily Hours of Hearing Aid Use — 7.37; 7.20 Daily hours — p=0.92
Summary
The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Average Daily Hours of Hearing Aid Use |
7.37; 7.20 | 0.92 |
| SECONDARY Treatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale |
4.78; 4.78 | 0.87 |
| SECONDARY Ability to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire |
4.25; 4.29 | 0.66 |
| SECONDARY Hearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire |
7.33; 7.16 | 0.38 |
Eligibility Criteria
To be eligible for the current study, participants must:
- have been eligible for and participated in the hearing intervention arm of the ACHIEVE trial (see original eligibility criteria below)
- agree to be randomized to receive continued hearing care via either a telehealth or conventional delivery model, and
- agree to participate in the follow-up study.
Original ACHIEVE Inclusion Criteria:
- Age 70-84 years
- Community-dwelling, fluent English speaker
- Availability of participant in area for study duration
- Adult-onset hearing impairment, defined as four-frequency pure tone average (PTA, 0.5-4 kilohertz (kHz), better ear) ≥30 decibel (dB) hearing level (HL) (decibels hearing level) & 15 dB in two or more contiguous frequencies in both ears
Data sourced from ClinicalTrials.gov (NCT05070429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.